Business Context and Reporting Period
This Form 8-K is a current report filed by Klotho Neurosciences, Inc. (not Greenland Mines Ltd) on March 4, 2026. The filing discloses a material event under Item 7.01 (Regulation FD Disclosure): the Company issued a press release announcing its acquisition of Greenland Mines Corp.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for either Klotho Neurosciences, Inc. or Greenland Mines Corp. This document serves solely as a disclosure of the acquisition announcement and does not contain audited or unaudited financial statements.
Material Changes
- Acquisition Event: Klotho Neurosciences, Inc. announced the acquisition of Greenland Mines Corp. on March 4, 2026.
- Strategic Shift: The acquisition represents a significant change in the Company's business scope, moving from its core neuroscience operations into the mining sector, as implied by the target company's name.
Guidance, Outlook, and Risks
Management Commentary: The filing includes standard forward-looking statements regarding future commercial operations, expectations, and strategies related to the acquisition. These statements are based on current assumptions and are not guarantees of future performance.
Risks and Uncertainties: The Company explicitly warns that actual results may differ materially from projections due to factors including:
- Inability to implement business plans.
- Failure to identify or realize additional opportunities.
- Changes in the regulatory or competitive environment.
- General risks associated with the integration of the acquired entity.
Legal Disclaimer: The information in the press release (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other SEC filings.
Investor Verification Checklist
- Verify the specific terms of the acquisition agreement (e.g., purchase price, payment structure) in the attached press release (Exhibit 99.1), as they are not detailed in the 8-K body.
- Confirm the strategic rationale for a neuroscience company acquiring a mining entity.
- Review subsequent filings for detailed financial impact analysis and integration plans.
- Assess the regulatory approvals required for the transaction, if any.